Ventricular myosin modifies in vitro step-size when phosphorylated

Yihua Wang, Katalin Ajtai, Thomas P Burghardt

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Cardiac and skeletal muscle myosins have the central role in contraction transducing ATP free energy into the mechanical work of moving actin. Myosin has a motor domain containing ATP and actin binding sites and a lever-arm that undergoes rotation impelling bound actin. The lever-arm converts torque generated in the motor into the linear displacement known as step-size. The myosin lever-arm is stabilized by bound essential and regulatory light chains (ELC and RLC). RLC phosphorylation at S15 is linked to modified lever-arm mechanical characteristics contributing to myosin filament based contraction regulation and to the response of the muscle to disease. Myosin step-size was measured using a novel quantum dot (Qdot) assay that previously confirmed a 5. nm step-size for fast skeletal myosin and multiple unitary steps, most frequently 5 and 8. nm, and a rare 3. nm displacement for β cardiac myosin (βMys). S15 phosphorylation in βMys is now shown to change step-size distribution by advancing the 8. nm step frequency. After phosphorylation, the 8. nm step is the dominant myosin step-size resulting in significant gain in the average step-size. An increase in myosin step-size will increase the amount of work produced per ATPase cycle. The results indicate that RLC phosphorylation modulates work production per ATPase cycle suggesting the mechanism for contraction regulation by the myosin filament.

Original languageEnglish (US)
Pages (from-to)231-237
Number of pages7
JournalJournal of Molecular and Cellular Cardiology
Volume72
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Ventricular Myosins
Myosins
Phosphorylation
Cardiac Myosins
Adenosine Triphosphatases
Actins
Skeletal Muscle Myosins
In Vitro Techniques
Quantum Dots
Torque
Adenosine Triphosphate
Binding Sites
Light
Muscles

Keywords

  • Actin-activated ATPase
  • Cardiac myosin RLC phosphorylation
  • In vitro motility
  • Qdot assay
  • Ventricular myosin step-size

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Ventricular myosin modifies in vitro step-size when phosphorylated. / Wang, Yihua; Ajtai, Katalin; Burghardt, Thomas P.

In: Journal of Molecular and Cellular Cardiology, Vol. 72, 2014, p. 231-237.

Research output: Contribution to journalArticle

Wang, Yihua ; Ajtai, Katalin ; Burghardt, Thomas P. / Ventricular myosin modifies in vitro step-size when phosphorylated. In: Journal of Molecular and Cellular Cardiology. 2014 ; Vol. 72. pp. 231-237.
@article{07ad47eb4cef47f6b31e15f63cd0804b,
title = "Ventricular myosin modifies in vitro step-size when phosphorylated",
abstract = "Cardiac and skeletal muscle myosins have the central role in contraction transducing ATP free energy into the mechanical work of moving actin. Myosin has a motor domain containing ATP and actin binding sites and a lever-arm that undergoes rotation impelling bound actin. The lever-arm converts torque generated in the motor into the linear displacement known as step-size. The myosin lever-arm is stabilized by bound essential and regulatory light chains (ELC and RLC). RLC phosphorylation at S15 is linked to modified lever-arm mechanical characteristics contributing to myosin filament based contraction regulation and to the response of the muscle to disease. Myosin step-size was measured using a novel quantum dot (Qdot) assay that previously confirmed a 5. nm step-size for fast skeletal myosin and multiple unitary steps, most frequently 5 and 8. nm, and a rare 3. nm displacement for β cardiac myosin (βMys). S15 phosphorylation in βMys is now shown to change step-size distribution by advancing the 8. nm step frequency. After phosphorylation, the 8. nm step is the dominant myosin step-size resulting in significant gain in the average step-size. An increase in myosin step-size will increase the amount of work produced per ATPase cycle. The results indicate that RLC phosphorylation modulates work production per ATPase cycle suggesting the mechanism for contraction regulation by the myosin filament.",
keywords = "Actin-activated ATPase, Cardiac myosin RLC phosphorylation, In vitro motility, Qdot assay, Ventricular myosin step-size",
author = "Yihua Wang and Katalin Ajtai and Burghardt, {Thomas P}",
year = "2014",
doi = "10.1016/j.yjmcc.2014.03.022",
language = "English (US)",
volume = "72",
pages = "231--237",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Ventricular myosin modifies in vitro step-size when phosphorylated

AU - Wang, Yihua

AU - Ajtai, Katalin

AU - Burghardt, Thomas P

PY - 2014

Y1 - 2014

N2 - Cardiac and skeletal muscle myosins have the central role in contraction transducing ATP free energy into the mechanical work of moving actin. Myosin has a motor domain containing ATP and actin binding sites and a lever-arm that undergoes rotation impelling bound actin. The lever-arm converts torque generated in the motor into the linear displacement known as step-size. The myosin lever-arm is stabilized by bound essential and regulatory light chains (ELC and RLC). RLC phosphorylation at S15 is linked to modified lever-arm mechanical characteristics contributing to myosin filament based contraction regulation and to the response of the muscle to disease. Myosin step-size was measured using a novel quantum dot (Qdot) assay that previously confirmed a 5. nm step-size for fast skeletal myosin and multiple unitary steps, most frequently 5 and 8. nm, and a rare 3. nm displacement for β cardiac myosin (βMys). S15 phosphorylation in βMys is now shown to change step-size distribution by advancing the 8. nm step frequency. After phosphorylation, the 8. nm step is the dominant myosin step-size resulting in significant gain in the average step-size. An increase in myosin step-size will increase the amount of work produced per ATPase cycle. The results indicate that RLC phosphorylation modulates work production per ATPase cycle suggesting the mechanism for contraction regulation by the myosin filament.

AB - Cardiac and skeletal muscle myosins have the central role in contraction transducing ATP free energy into the mechanical work of moving actin. Myosin has a motor domain containing ATP and actin binding sites and a lever-arm that undergoes rotation impelling bound actin. The lever-arm converts torque generated in the motor into the linear displacement known as step-size. The myosin lever-arm is stabilized by bound essential and regulatory light chains (ELC and RLC). RLC phosphorylation at S15 is linked to modified lever-arm mechanical characteristics contributing to myosin filament based contraction regulation and to the response of the muscle to disease. Myosin step-size was measured using a novel quantum dot (Qdot) assay that previously confirmed a 5. nm step-size for fast skeletal myosin and multiple unitary steps, most frequently 5 and 8. nm, and a rare 3. nm displacement for β cardiac myosin (βMys). S15 phosphorylation in βMys is now shown to change step-size distribution by advancing the 8. nm step frequency. After phosphorylation, the 8. nm step is the dominant myosin step-size resulting in significant gain in the average step-size. An increase in myosin step-size will increase the amount of work produced per ATPase cycle. The results indicate that RLC phosphorylation modulates work production per ATPase cycle suggesting the mechanism for contraction regulation by the myosin filament.

KW - Actin-activated ATPase

KW - Cardiac myosin RLC phosphorylation

KW - In vitro motility

KW - Qdot assay

KW - Ventricular myosin step-size

UR - http://www.scopus.com/inward/record.url?scp=84901335911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901335911&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2014.03.022

DO - 10.1016/j.yjmcc.2014.03.022

M3 - Article

C2 - 24726887

AN - SCOPUS:84901335911

VL - 72

SP - 231

EP - 237

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -